Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS591243B2 - Serum cholesterol increase inhibitor isolated from defatted rice bran - Google Patents
[go: Go Back, main page]

JPS591243B2 - Serum cholesterol increase inhibitor isolated from defatted rice bran - Google Patents

Serum cholesterol increase inhibitor isolated from defatted rice bran

Info

Publication number
JPS591243B2
JPS591243B2 JP54049722A JP4972279A JPS591243B2 JP S591243 B2 JPS591243 B2 JP S591243B2 JP 54049722 A JP54049722 A JP 54049722A JP 4972279 A JP4972279 A JP 4972279A JP S591243 B2 JPS591243 B2 JP S591243B2
Authority
JP
Japan
Prior art keywords
rice bran
serum cholesterol
defatted rice
cholesterol increase
increase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54049722A
Other languages
Japanese (ja)
Other versions
JPS55141415A (en
Inventor
久明 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOOSOO YUSHI KK
Original Assignee
BOOSOO YUSHI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOOSOO YUSHI KK filed Critical BOOSOO YUSHI KK
Priority to JP54049722A priority Critical patent/JPS591243B2/en
Publication of JPS55141415A publication Critical patent/JPS55141415A/en
Publication of JPS591243B2 publication Critical patent/JPS591243B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 本発明は、脱脂米ぬかの利用開発をはかり、これを原料
とした血性コレステロール上昇抑制物質を提供するにあ
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention aims to develop the use of defatted rice bran, and provides a substance that suppresses the rise in blood cholesterol using this as a raw material.

従来、ヘクチン、コンニャク、マンナン等の難消化性成
分の多いものが血清コレステロール上昇を抑えることが
知られて居り、文献等ではヒトの消化酵素では消化困難
乃至不可能な成分を「ダイエタリー・ファイバー」と云
う新しい概念で呼んで居り、従来の「クルード・ファイ
バー」とは明確に区別し、より広い難消化性成分の意味
で使用して居り大腸がんの発生抑止、微生物の排出する
有害物、有毒色素等の吸着や、血清コレステロール値の
正常化等に「ダイエタリーファイバー」が注目され、木
材パルプや、繊維質農水産物の穀類、豆類や海そう等、
或いは米ぬか、フスマ等の穀類外皮に関心が寄せられて
いるが、本発明者の研究によれば、米ぬかや脱脂米ぬか
は確かに、セルロース、ヘミセルロース、リグニン等の
難消化性成分を比較的多量に含んでいるので、これを摂
取すれば、血清コレステロールの上昇を抑制する如く推
測されるが、事実は、その効果は実質上記められなかっ
た。
Conventionally, it has been known that foods containing many indigestible ingredients such as hectin, konjac, and mannan suppress increases in serum cholesterol, and in the literature, ingredients that are difficult or impossible to digest with human digestive enzymes are called "dietary fiber." It is clearly distinguished from the conventional "crude fiber" and is used in a broader sense of indigestible ingredients, which can inhibit the occurrence of colorectal cancer, harmful substances excreted by microorganisms, "Dietary fiber" has attracted attention for its ability to absorb toxic pigments and normalize serum cholesterol levels.
Alternatively, there is interest in grain hulls such as rice bran and bran, but according to the research of the present inventor, rice bran and defatted rice bran do indeed contain relatively large amounts of indigestible components such as cellulose, hemicellulose, and lignin. Although it is presumed that ingesting it would suppress the rise in serum cholesterol, the fact is that the effect was not substantially mentioned above.

本発明者は、特に米ぬかを脱脂処理した脱脂ぬかを原料
として、之から、澱粉質、たん白質を除いたとき、残滓
として得られるセルロース、ヘミセルロース、リグニン
を主成分とする物質が特に血清コレステロールの上昇を
抑止するに著効があることを知見した。
The present inventor has discovered that when starch and protein are removed from defatted rice bran, which is obtained by defatting rice bran, the residue obtained is a substance mainly composed of cellulose, hemicellulose, and lignin, which is particularly effective in reducing serum cholesterol. We found that it is highly effective in suppressing the rise in

次に、本発明を、か5る有効物質の好ましい有効な取得
方法の1例と共に詳細に説明する。
Next, the present invention will be explained in detail along with one example of a preferred and effective method for obtaining such an effective substance.

原料として用いる市販脱脂米ぬか(水分10.8%、粗
たん白17.0%、粗脂肪1.7%、粗繊維9.3係、
灰分11.2係、可溶性無窒素物50チ)にはへミセル
ローヌ12.5%、セルロース6.8%、リグニン3.
9係合計23.2%が含まれて居た。
Commercially available defatted rice bran used as raw material (moisture 10.8%, crude protein 17.0%, crude fat 1.7%, crude fiber 9.3%,
Ash content: 11.2%, soluble nitrogen-free matter: 50%) Hemicellrone: 12.5%, cellulose: 6.8%, lignin: 3.
A total of 23.2% of the 9 sections were included.

尚、そのヘミセルロースの70係はペントースで残り3
0チはヘキソース並びにウロン酸であり、セルロースは
、90%がヘキソースで10%がペントースから構成さ
れていた。
In addition, the 70th part of hemicellulose is a pentose, and the remaining 3
Oti was hexose and uronic acid, and cellulose was composed of 90% hexose and 10% pentose.

か\る脱肪米ぬか原料に対して、0.1%グルコアミラ
ーゼ液(長潮産業■活性2.89ユニット/my )を
作用させ、含有澱粉質を分解し除去した。
A 0.1% glucoamylase solution (Nagao Sangyo activity: 2.89 units/my) was applied to the defatted rice bran raw material to decompose and remove the starch contained therein.

得られた残渣より、たん白質、灰分を除去するため、ラ
ウリル硫酸ナトリウム、エチレンジアミン四さく酸を主
成分とする溶媒を水に溶解し、更に之に亜硫酸ソーダを
添加溶解した溶剤で抽出除去し、次で得られる残渣を充
分洗浄し、乾燥して本発明の残滓、即ち、分離生成物を
得た。
In order to remove protein and ash from the obtained residue, a solvent containing sodium lauryl sulfate and ethylenediaminetetraslicic acid as main components was dissolved in water, and sodium sulfite was further added and dissolved in the solvent, which was then extracted and removed. The resulting residue was thoroughly washed and dried to obtain the residue of the present invention, ie, the separated product.

これを以下便宜上NDF分画部と称する。This is hereinafter referred to as the NDF fractionation section for convenience.

該NDF分画部は、ヘミセルロース47.5%、セルロ
ース29.3%、リグニン16.3係、全窒素1係、灰
分1.4係の成分組成であった。
The NDF fraction had a composition of 47.5% hemicellulose, 29.3% cellulose, 16.3 parts lignin, 1 part total nitrogen, and 1.4 parts ash.

又その外観は、若干黄色を帯びた白色の粉末であった。The appearance was a slightly yellowish white powder.

このようにして得られたNDF分画部を、稀酸により加
水分解しヘミセルロースを分解し、その残滓を充分洗浄
シ、乾燥して、セルロース60.2%、リグニン33.
4%、ヘミセルロース5%、全窒素0.8%、灰分3.
7%の成分組成から成るヘミセルロースの実質上除かれ
た分離生成物を得た。
The NDF fraction thus obtained was hydrolyzed with dilute acid to decompose the hemicellulose, and the residue was thoroughly washed and dried, resulting in 60.2% cellulose and 33% lignin.
4%, hemicellulose 5%, total nitrogen 0.8%, ash 3.
A separated product substantially free of hemicellulose with a component composition of 7% was obtained.

(以下之をADF分画部と称する)。(Hereinafter, this will be referred to as the ADF fractionation section).

このようにして得られたNDF分画部とADF分画部に
つき、以下詳述する如き、ラットの飼育試験を行なった
結果血清コレステロールの上昇抑制に対し、NDF分画
部は著しい効果があったが、ADF分画部は効果が認め
られなかった。
The thus obtained NDF fraction and ADF fraction were subjected to a rat feeding test as detailed below, and the results showed that the NDF fraction had a remarkable effect on suppressing the rise in serum cholesterol. However, no effect was observed in the ADF fraction.

実験動物は、体重約70gのウィスター不離ラットを標
準飼料で7日間予備飼育したのち、一群6匹ずつ4群に
分け、下記する実験飼料を投与し、10日間飼育した。
The experimental animals were Wistar detachment rats weighing approximately 70 g, which were preliminarily fed with a standard diet for 7 days, then divided into 4 groups of 6 animals per group, administered with the following experimental diet, and kept for 10 days.

各群の平均体重ならびに予備飼育期間中の体重増加量は
略等しくなるよう配慮した。
Care was taken to ensure that the average body weight of each group and the amount of weight gain during the preliminary rearing period were approximately equal.

ラットは6※※室に区切られた金網製ケージに一匹ずつ
入れ、室温22±1℃の飼育室で飼育し、飼料並びに水
は自由に摂取させた。
Each rat was placed in a wire mesh cage divided into 6* rooms, kept in a breeding room at a room temperature of 22±1°C, and given free access to food and water.

実験飼料の組成はコレステロール代謝試験に用いられて
いる一般的なものである。
The composition of the experimental feed was that commonly used in cholesterol metabolism studies.

標準飼料:しよ糖、カゼインを主成分とし、コレステロ
ール、胆汁酸を含まない飼料 対照飼料:しよ糖、カゼインを主成分とし、コレステロ
ール1係、胆汁酸0.25%を含 む飼料 試験飼料I:対照飼料の糖質の1部をNDF分画部5係
で置換した飼料 試験飼料■:対照飼料の糖質の1部をADF分画部5係
で置換した飼料 ラットは、実験終了後、斬首、採血、開腹後学法の分析
法により血清コレステロール、肝臓コレステロールを測
定し、下表1の結果を得た。
Standard feed: Feed containing sucrose and casein as main ingredients, without cholesterol and bile acids Control feed: Feed with sucrose and casein as main ingredients, cholesterol 1 part, and bile acid 0.25% Test feed I : A test diet in which part of the carbohydrates in the control diet was replaced with NDF fraction part 5. Serum cholesterol and liver cholesterol were measured using analytical methods after decapitation, blood sampling, and laparotomy, and the results shown in Table 1 below were obtained.

上記表から明らかな通り、血清コレステロール値は、N
DF飼料群は対照飼料群に比べλに低下して居り、ND
F分画部の著効が認められた。
As is clear from the table above, the serum cholesterol level is
The DF feed group had a decrease in λ compared to the control feed group, and the ND
A remarkable effect was observed in the F fraction.

この実験データを推計学的処理により有意差の検定を行
なった結果、5%と云う小さい危険率で有意に低下して
いた。
This experimental data was tested for significance using stochastic processing, and as a result, it was found that there was a significant decrease with a small risk rate of 5%.

NDF飼料群は又肝臓コレステロール値についても、対
照飼料群に比べ低下し、NDF分画部の効果が認められ
た。
The NDF feed group also had lower liver cholesterol levels than the control feed group, demonstrating the effect of the NDF fraction.

之に対し、ADF飼料群は対照飼料群に比し、血清コレ
ステロールの低下が認められるが、肝臓コレステロール
については、却って増大し、ADF分画部は好ましくな
いことが分る。
On the other hand, serum cholesterol was found to be lower in the ADF feed group than in the control feed group, but liver cholesterol was on the contrary increased, indicating that the ADF fraction was not preferable.

このように、本発明によるときは、脱脂ぬかを原料トシ
、これより、ヘミセルロース、セルロース、リグニンを
主成分とする分離生成物は、血清コレステロールの上昇
抑制作用に著しく効果かある。
As described above, according to the present invention, the separated product made from defatted bran as a raw material and whose main components are hemicellulose, cellulose, and lignin is extremely effective in suppressing the rise in serum cholesterol.

次に本発明のNDF分画部を得るための好ましい分取法
を説明する。
Next, a preferred fractionation method for obtaining the NDF fraction of the present invention will be explained.

市販脱脂米ぬかを原料とし、60メツシユの篩でふり分
け、通過部100gを0.1 %グルコアミラーゼ液1
tに懸濁させ、40℃、24時間反応させた。
Using commercially available defatted rice bran as a raw material, sieve it through a 60-mesh sieve, and add 100 g of the passed portion to 0.1% glucoamylase solution 1
The mixture was suspended in water and reacted at 40°C for 24 hours.

ついで、3000rpIfi、5分遠心分離し、上澄液
を除去し、残渣にラウリル硫酸ナトリウム、エチレンジ
アミン四さく酸を主成分とする溶媒1t(ラウリル硫酸
ナトリウム30g1エチレンジアミン四さく酸19g1
四ホウナトリウム7g1りん酸第二ナトリウム5g1エ
チレングリコールモノエチルエーテル10m1を水に溶
解し1tとしたものバ亜硫酸ナトリウム50g1デカリ
ン200rILlを加え、還流冷却器を付して煮沸した
Then, it was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed, and the residue was mixed with 1 t of a solvent containing sodium lauryl sulfate and ethylenediaminetetrasuccinic acid as main components (30 g of sodium lauryl sulfate, 19 g of ethylenediamine tetrasuccinic acid,
7 g of sodium tetraboronate, 5 g of dibasic sodium phosphate, 10 ml of ethylene glycol monoethyl ether were dissolved in water to make 1 t, 50 g of sodium sulfite, 200 rIL of decalin were added, and the mixture was boiled with a reflux condenser.

煮沸後3000rl)11,5分遠心分離、上澄液を除
去し、残渣を熱水1tで洗浄し、乾燥してNDF分画部
25gを得た。
After boiling, the mixture was centrifuged for 11.5 minutes at 3,000 rl, the supernatant was removed, and the residue was washed with 1 t of hot water and dried to obtain 25 g of NDF fraction.

NDF分画部の組成は、乾燥基準でヘミセルロース47
.5%、セルロース29.3%、リグニン16.3%、
全窒素1.0係、灰分1.4%の成分組成であった。
The composition of the NDF fraction is hemicellulose 47% on a dry basis.
.. 5%, cellulose 29.3%, lignin 16.3%,
The composition had a total nitrogen content of 1.0% and an ash content of 1.4%.

尚、灰分の除去は、任意であり、従って、亜硫酸ナトリ
ウムを前記溶媒中に添加することは省略でき、又デカリ
ンの添加は、消泡剤として作用し、作業を円滑にする。
Incidentally, the removal of ash is optional, and therefore the addition of sodium sulfite to the solvent can be omitted, and the addition of decalin acts as an antifoaming agent and facilitates the work.

尚、ADF分画試料の作成は、上記により得られた一N
DF分画試料を、更に、臭化エチルトリメチルアンモニ
ウム、消泡剤を添加した稀酸水溶液で処理し、その残滓
を充分洗浄して得られる。
The ADF fractionation sample was prepared using the 1N obtained above.
The DF fraction sample is further treated with a dilute acid aqueous solution containing ethyltrimethylammonium bromide and an antifoaming agent, and the residue is thoroughly washed.

Claims (1)

【特許請求の範囲】[Claims] 1 脱脂米ぬかを原料とし、これをアミラーゼによりで
ん粉質を分解除去し、次で溶媒でたん白質を溶解除去し
、残滓として得られるヘミセルロース、セルロース、リ
グニンを主成分とする血清コレステロール上昇抑制物質
1. A serum cholesterol increase-inhibiting substance whose main components are hemicellulose, cellulose, and lignin obtained by using defatted rice bran as a raw material, decomposing and removing starch with amylase, and then dissolving and removing proteins with a solvent.
JP54049722A 1979-04-24 1979-04-24 Serum cholesterol increase inhibitor isolated from defatted rice bran Expired JPS591243B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP54049722A JPS591243B2 (en) 1979-04-24 1979-04-24 Serum cholesterol increase inhibitor isolated from defatted rice bran

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54049722A JPS591243B2 (en) 1979-04-24 1979-04-24 Serum cholesterol increase inhibitor isolated from defatted rice bran

Publications (2)

Publication Number Publication Date
JPS55141415A JPS55141415A (en) 1980-11-05
JPS591243B2 true JPS591243B2 (en) 1984-01-11

Family

ID=12839074

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54049722A Expired JPS591243B2 (en) 1979-04-24 1979-04-24 Serum cholesterol increase inhibitor isolated from defatted rice bran

Country Status (1)

Country Link
JP (1) JPS591243B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171570A (en) * 1989-12-08 1992-12-15 Lotte Company Limited Substance having suppressing function for diseases relating to increase in cholesterol, and foods and drinks in which it is used
JP2588615B2 (en) * 1989-12-08 1997-03-05 株式会社ロッテ Blood cholesterol elevation inhibitor
JP2814172B2 (en) * 1992-09-08 1998-10-22 日本甜菜製糖株式会社 Blood lipid regulators derived from edible plants
JP5701471B2 (en) * 2007-02-07 2015-04-15 大関株式会社 Plant-derived material with high indigestible content

Also Published As

Publication number Publication date
JPS55141415A (en) 1980-11-05

Similar Documents

Publication Publication Date Title
Chaturvedi et al. Hypocholesterolemic effect of amaranth seeds (Amaranthus esculantus)
Dam et al. The occurrence and chemical nature of vitamin K
Delaney et al. Evaluation of the toxicity of concentrated barley β-glucan in a 28-day feeding study in Wistar rats
De Groot et al. Two-year feeding and multigeneration studies in rats on five chemically modified starches
JP2787252B2 (en) Colorectal cancer inhibitor
Carré et al. Digestion of polysaccharides, protein and lipids by adult cockerels fed on diets containing a pectic cell-wall material from white lupin (Lupinus albus L.) cotyledon
Norin et al. Strain differences in faecal tryptic activity of germ-free and conventional rats
Thomas et al. Effect of blackgram fiber (Phaseolus mungo) on hepatic hydroxymethylglutaryl-CoA reductase activity, cholesterogenesis and cholesterol degradation in rats
JPS591243B2 (en) Serum cholesterol increase inhibitor isolated from defatted rice bran
JP2986324B2 (en) Diet / Diabetic Food
Ishihara et al. Changes of gastric mucus glycoproteins with aspirin administration in rats
MAEDA et al. Occurrence of dermatitis in rats fed a cholesterol diet containing field horsetail (Equisetum arvense L.)
JPS63216822A (en) Improving substance for lipid metabolism
Grenby Phytates in decalcification tests in vitro
JP2814172B2 (en) Blood lipid regulators derived from edible plants
JP2662530B2 (en) Food additives and their use
US20050064040A1 (en) Processes for improving binding capability and biological digestability
JPH0363561B2 (en)
JPS63185931A (en) Removal of blood serum cholesterol rise promoting factor from wheat bran
JPH06340532A (en) Agent for suppressing or reducing elevation of blood lipids
JP3222265B2 (en) flour
LU602295B1 (en) Barley fiberin compound cellulose composition preparation and its application in wooling preparation
JPH0434527B2 (en)
JPH046686B2 (en)
JPH0223152B2 (en)